Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309616871> ?p ?o ?g. }
- W4309616871 endingPage "17" @default.
- W4309616871 startingPage "1" @default.
- W4309616871 abstract "To explore the effect of tanshinone IIA on diabetic retinopathy (DR) and its mechanism.GeneCards and OMM databases were used to mine DR-related genes. The chemical structure of tanshinone IIA was searched by PubChem, and the potential target was predicted by PharmMapper. Cystape 3.8.2 was used to visualize and analyze the tanshinone IIA-DR protein interaction network. DAVID ver 6.8 data were used to perform enrichment analysis of the tanshinone IIA-DR protein interaction network. Then animal experiments were carried out to further explore the mechanism of tanshinone IIA in the treatment of DR. Male SD rats were intraperitoneally injected with streptozotocin to establish a diabetes model and were randomly divided into a model group, a low-dose tanshinone IIA group and a high-dose group. Normal rats served as the control group. Hematoxylin-eosin (HE) staining was used to observe the structural changes of the retina; the SOD, GSH-Px, and MDA levels in the retina were detected by the xanthine oxidase method; the expression of VEGF, IL-1β, IL-6, TNF-α, and caspase-3 mRNA were detected by qRT-PCR; and the Bcl-2, Bax, and VEGFA proteins were determined by the western blot.A total of 213 tanshinone IIA potential targets and 223 DR-related genes were obtained. The enrichment analysis showed that tanshinone IIA may regulate hypoxia, oxidative stress, positive regulation of ERK1 and ERK2 cascade, steroid hormone-mediated signaling pathway, inflammatory response, angiogenesis, VEGF signaling pathway, apoptosis, PI3K-Akt signaling pathway, TNF signaling pathway, and biological processes and signaling pathways. The structure of the retina in the normal control group was clear, the retina in the model group was not clear, the nerve fiber layer was edema, the retinal cell layers of the tanshinone IIA low-dose group are arranged neatly, the inner and outer nuclear layers are slightly disordered, and the tanshinone IIA low-dose group was large. The structure of the mouse retina was further improved compared with the low-dose tanshinone IIA group. Compared with the model group, the retinal tissue SOD and GSH-PX of rats in the tanshinone IIA group increased, and the MDA level decreased (P < 0.05). Compared with the model group, the expression of VEGF, IL-1β, IL-6, TNF-α, and caspase-3 mRNA in the retina of tanshinone IIA groups was significantly reduced (P < 0.01). Compared with the model group, the Bcl-2 protein in the tanshinone IIA groups increased, while the Bax and VEGFA proteins decreased (P < 0.05).Tanshinone IIA may improve the morphological performance of the retina of diabetic rats and inhibit DR, the mechanism of which may be anti-inflammatory, antiangiogenesis, etc." @default.
- W4309616871 created "2022-11-28" @default.
- W4309616871 creator A5018357158 @default.
- W4309616871 creator A5027371972 @default.
- W4309616871 creator A5035257015 @default.
- W4309616871 creator A5056010319 @default.
- W4309616871 creator A5065770907 @default.
- W4309616871 creator A5075155055 @default.
- W4309616871 date "2022-11-17" @default.
- W4309616871 modified "2023-09-27" @default.
- W4309616871 title "Study on the Antioxidant Effect of Tanshinone IIA on Diabetic Retinopathy and Its Mechanism Based on Integrated Pharmacology" @default.
- W4309616871 cites W1969937534 @default.
- W4309616871 cites W1972852504 @default.
- W4309616871 cites W1976896312 @default.
- W4309616871 cites W1990048793 @default.
- W4309616871 cites W1998707239 @default.
- W4309616871 cites W2008128312 @default.
- W4309616871 cites W2010204260 @default.
- W4309616871 cites W2018141371 @default.
- W4309616871 cites W2023631795 @default.
- W4309616871 cites W2034922411 @default.
- W4309616871 cites W203949027 @default.
- W4309616871 cites W2042952308 @default.
- W4309616871 cites W2055814753 @default.
- W4309616871 cites W2063057213 @default.
- W4309616871 cites W2074010097 @default.
- W4309616871 cites W2075008661 @default.
- W4309616871 cites W2088950533 @default.
- W4309616871 cites W2091631475 @default.
- W4309616871 cites W2095189946 @default.
- W4309616871 cites W2096173332 @default.
- W4309616871 cites W2104158890 @default.
- W4309616871 cites W2113150136 @default.
- W4309616871 cites W2116350550 @default.
- W4309616871 cites W2119412782 @default.
- W4309616871 cites W2123634291 @default.
- W4309616871 cites W2158217645 @default.
- W4309616871 cites W2162883084 @default.
- W4309616871 cites W2163007294 @default.
- W4309616871 cites W2261519740 @default.
- W4309616871 cites W2265165828 @default.
- W4309616871 cites W2345328813 @default.
- W4309616871 cites W2385884905 @default.
- W4309616871 cites W2417445428 @default.
- W4309616871 cites W2474747771 @default.
- W4309616871 cites W2530853433 @default.
- W4309616871 cites W2533964947 @default.
- W4309616871 cites W2582063619 @default.
- W4309616871 cites W2600827172 @default.
- W4309616871 cites W2601494682 @default.
- W4309616871 cites W2609340129 @default.
- W4309616871 cites W2611425558 @default.
- W4309616871 cites W2734602934 @default.
- W4309616871 cites W2760115228 @default.
- W4309616871 cites W2764077932 @default.
- W4309616871 cites W2766987228 @default.
- W4309616871 cites W2767338841 @default.
- W4309616871 cites W2793401320 @default.
- W4309616871 cites W2809809041 @default.
- W4309616871 cites W2811133902 @default.
- W4309616871 cites W2883528163 @default.
- W4309616871 cites W2900050340 @default.
- W4309616871 cites W2911374797 @default.
- W4309616871 cites W2914592516 @default.
- W4309616871 cites W2915895704 @default.
- W4309616871 cites W2916667086 @default.
- W4309616871 cites W2938356200 @default.
- W4309616871 cites W2939034184 @default.
- W4309616871 cites W2943410960 @default.
- W4309616871 cites W2967298236 @default.
- W4309616871 cites W2977766627 @default.
- W4309616871 cites W2985669072 @default.
- W4309616871 cites W2985753530 @default.
- W4309616871 cites W2987780301 @default.
- W4309616871 cites W2989888362 @default.
- W4309616871 cites W2993217589 @default.
- W4309616871 cites W3007180795 @default.
- W4309616871 cites W3009949620 @default.
- W4309616871 cites W3011099182 @default.
- W4309616871 cites W3024085885 @default.
- W4309616871 cites W3025591880 @default.
- W4309616871 cites W3027005199 @default.
- W4309616871 cites W3091790375 @default.
- W4309616871 cites W3094240089 @default.
- W4309616871 cites W3096755862 @default.
- W4309616871 cites W3106316616 @default.
- W4309616871 cites W3133213699 @default.
- W4309616871 cites W3134459815 @default.
- W4309616871 cites W4211031298 @default.
- W4309616871 cites W4211205882 @default.
- W4309616871 cites W4244017022 @default.
- W4309616871 cites W575331073 @default.
- W4309616871 cites W950299365 @default.
- W4309616871 doi "https://doi.org/10.1155/2022/9990937" @default.
- W4309616871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36437835" @default.
- W4309616871 hasPublicationYear "2022" @default.
- W4309616871 type Work @default.
- W4309616871 citedByCount "0" @default.